Announcements Trials

Browse Landscape

Phase

Phase EARLY_PHASE1 1

Status

Terminated 3 Unknown 1 Recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Melanoma 7 Leukemia, Myeloid, Acute 6 Breast Neoplasms 6 Colorectal Neoplasms 5 Carcinoma, Non-Small-Cell Lung 5 Ovarian Neoplasms 4 Neoplasm Metastasis 4 Triple Negative Breast Neoplasms 3 Skin Neoplasms 3 Mesothelioma, Malignant 3 Lymphoma, Non-Hodgkin 3 Uveal Melanoma 2 Uterine Cervical Neoplasms 2 Stomach Neoplasms 2 Sarcoma 2 Recurrence 2 Rectal Neoplasms 2 Pleural Effusion, Malignant 2 Neuroblastoma 2 Neoplasms 2 Multiple Myeloma 2 Lung Neoplasms 2 Leukemia, Myeloid 2 Leukemia 2 Head and Neck Neoplasms 2 Glioblastoma 2 Esophageal Neoplasms 2 Carcinoma, Merkel Cell 2 Urinary Bladder Neoplasms 1 Turcot syndrome 1

Interventions

Cisplatin 12 pembrolizumab 11 Magnetic Resonance Spectroscopy 11 Specimen Handling 10 Paclitaxel 6 Platinum 5 Cyclophosphamide 5 1,2-diaminocyclohexaneplatinum II citrate 5 fludarabine 4 durvalumab 4 cemiplimab 4 Radiotherapy, Intensity-Modulated 4 Radiotherapy 3 Pemetrexed 3 Oxaliplatin 3 Nivolumab 3 Fluorouracil 3 Cetuximab 3 Carboplatin 3 Biopsy 3 poly ICLC 2 fludarabine phosphate 2 cabozantinib 2 atezolizumab 2 Radiation 2 Ipilimumab 2 Interviews as Topic 2 Heavy Ion Radiotherapy 2 Gemcitabine 2 Drug Therapy 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Carcinoma × Interleukin-2 × Clear all

NCT05141474 2024-11-07

NEXTGENTIL-ACT

Vall d'Hebron Institute of Oncology

Phase EARLY_PHASE1 Recruiting

Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡